|
ZNF354A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.89528426075958E-14 |
| Normal-vs-Stage2 |
3.90169999997525E-06 |
| Normal-vs-Stage3 |
5.38458166943201E-14 |
| Normal-vs-Stage4 |
2.00809999739704E-08 |
| Stage1-vs-Stage2 |
3.514800E-01 |
| Stage1-vs-Stage3 |
1.360200E-02 |
| Stage1-vs-Stage4 |
6.630800E-01 |
| Stage2-vs-Stage3 |
1.823810E-02 |
| Stage2-vs-Stage4 |
3.065600E-01 |
| Stage3-vs-Stage4 |
2.072600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.1094237467878E-15 |
| Normal-vs-AfricanAmerican |
3.50660000036918E-07 |
| Normal-vs-Asian |
1.67298000000038E-05 |
| Caucasian-vs-AfricanAmerican |
5.372400E-01 |
| Caucasian-vs-Asian |
6.104300E-02 |
| AfricanAmerican-vs-Asian |
6.944400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.40400033213461E-10 |
| Normal-vs-Female |
1.62481139653892E-12 |
| Male-vs-Female |
2.125600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.84141590864328E-12 |
| Normal-vs-Age(41-60Yrs) |
9.43689570931383E-15 |
| Normal-vs-Age(61-80Yrs) |
1.12419999975799E-08 |
| Normal-vs-Age(81-100Yrs) |
6.303400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.202800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.138000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.642000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.495620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.405800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.387600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.517200E-03 |
| Classical-VS-Follicular |
7.255600E-02 |
| Classical-VS-Other |
7.106800E-01 |
| Classical-VS-Normal |
2.25679996912476E-09 |
| Tall-VS-Follicular |
1.022520E-04 |
| Tall-VS-Other |
5.708300E-02 |
| Tall-VS-Normal |
3.24895665926306E-12 |
| Follicular-VS-Other |
8.347600E-01 |
| Follicular-VS-Normal |
1.58500000002615E-06 |
| Other-VS-Normal |
2.389600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.00549568671227E-11 |
| Normal-vs-N1 |
1.01709999977828E-07 |
| N0-vs-N1 |
9.259200E-01 |
|
|
